Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $113
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Larry Biegelsen maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $103 to $113.
Wells Fargo analyst Larry Biegelsen maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and raises the price target from $103 to $113.